Although Oklahoma is fortunate to have a cadre of basic science investigators who receive federal and national support, we lag behind in our potential in generating well-funded programs in clinical and translational research. The FOA backs this in its statement that tremendous challenges and opportunities remain for pursuing activities aligned with the NIH's growing interest and focus on clinical and translational research in IDeA states. Given the disparities that exist in the infrastructure, it is imperative that innovative new strategies are designed to help investigators from Oklahoma and other IDeA states to compete successfully for National and Federal Funding. To achieve these goals, it is necessary to create an environment that facilitates the expansion and acceleration of our clinical and translational research programs, focusing our efforts on the issues which remain the major health challenges to our state, to our OSCTR IDeA partner states and our underserved communities with health disparities. As such, our emphasis will be on clinical and translational research focused on diabetes, accelerated heart disease, obesity, cancer, arthritis, autoimmunity and issues important to childhood health. Our long-term goal is to improve our existing infrastructure and to provide the tools that investigators throughout Oklahoma and collaborating IDeA states need to attract new research dollars to the region from outside sources to support innovative and collaborative research programs. These funds are crucial to help address health issues and health disparities, which are major challenges for IDeA states. Our major objective is to establish a program that will provide the necessary infrastructure to support a clinical and translational pilot grant program. Our central hypothesis is that by providing early support in the form of strategic leadership, grant funding, and mentorship to investigators with meritorious projects, we will identify and train a new generation of well-trained, well-funded investigators who will be more readily equipped to translate scientific discoveries into practical applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
7U54GM104938-04
Application #
9068957
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
4
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Basu, Arpita; Schell, Jace; Scofield, R Hal (2018) Dietary fruits and arthritis. Food Funct 9:70-77
Smith, Joshua; McGhee, Phillip; Nguyen, Nathan et al. (2018) Question: In men with risk factors for coronary artery disease, does initiating lipid screening earlier than 35 years of age reduce cardiovascular events? J Okla State Med Assoc 111:560-561
Chou, Ann F; Homco, Juell B; Nagykaldi, Zsolt et al. (2018) Disseminating, implementing, and evaluating patient-centered outcomes to improve cardiovascular care using a stepped-wedge design: healthy hearts for Oklahoma. BMC Health Serv Res 18:404
Georgescu, Constantin; Wren, Jonathan D (2018) Algorithmic identification of discrepancies between published ratios and their reported confidence intervals and P-values. Bioinformatics 34:1758-1766
LaBryer, Lauren; Sharma, Rohan; Chaudhari, Kaustubh Suresh et al. (2018) Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report. J Investig Med High Impact Case Rep 6:2324709618765022
Hannafon, Bethany N; Ding, Wei-Qun (2018) miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ. Am J Pathol 188:542-549
Salvatore, Alicia L; Noonan, Carolyn J; Williams, Mary B et al. (2018) Social Support and Physical Activity Among American Indians in Oklahoma: Results From a Community-based Participatory Research Study. J Rural Health :
Karp, David R; Chong, Benjamin F; James, Judith A et al. (2018) Mock Recruitment for the Study of Antimalarials in Incomplete Lupus Erythematosus Trial. Arthritis Care Res (Hoboken) :
Pelikan, Richard C; Kelly, Jennifer A; Fu, Yao et al. (2018) Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks. Nat Commun 9:2905
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :

Showing the most recent 10 out of 252 publications